* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
Person Signing this Report on Behalf of Reporting Manager:
Name
Title
City, State
Date
Leora Pratt Levin/Gabi Last
V.P. Legal Counsel and Company Secretary/Chairman
Herzliya, Israel
7/31/2019
The securities reported herein are beneficially owned by Delek Group Ltd. or various direct or indirect, majority or wholly-owned subsidiaries of the Phoenix Holdings Ltd. (the "Subsidiaries"), including Excellence Investment Ltd. The Subsidiaries manage their own funds and/or the funds of others, including for holders of exchange-traded notes or various insurance policies, members of pension or provident funds, unit holders of mutual funds, and portfolio management clients. Delek Group Ltd. and each of the Subsidiaries operates under independent management and makes its own independent voting and investment decisions. Neither the filing of this Form 13F nor any of its contents shall be deemed to constitute an admission by either persons filing this Form 13F or by any of the Subsidiaries that a group exists for purposes of Section 13(d) of the Securities Exchange Act of 1934 or for any other purpose, and each reporting person disclaims the existence of any such group. In addition, each of the persons filing this Form 13F and the Subsidiaries disclaims any beneficial ownership of the securities covered by this report in excess of their actual pecuniary interest therein. This Statement shall not be construed as an admission by the persons filing this Form 13F or by the Subsidiaries that they are the beneficial owners of any of the Ordinary Shares covered by this Form 13F, and each of the persons filing this Form 13F and the Subsidiaries disclaims beneficial ownership of any such Ordinary Shares. Per informal guidance received from the Division of Investment Management, section 13(f) securities that are dual listed on a U.S. stock exchange and the Tel Aviv Stock Exchange were included in this Form 13F only if they were purchased in the U.S.
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.